Cannabis and IBD: Recent Research Insights
For individuals living with Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, finding a comprehensive management plan is often a journey of trial and error. Many patients explore medical cannabis as a complementary option. To help you stay informed, we have summarized recent findings from PubMed, the U.S. National Library of Medicine's database of peer-reviewed research.
It is important to remember that the science regarding cannabis and gastrointestinal health is still evolving. This information is provided for general educational purposes and is not medical advice. You should always talk to your physician before starting or changing a treatment plan.
Examining THC and IBD
Because more people with IBD are using cannabis, researchers are working to determine how effective these products actually are. A systematic review published in the Journal of Cannabis Research looked at both interventional trials and real-world, non-interventional studies involving cannabis products containing delta-9-tetrahydrocannabinol (THC). The researchers noted that findings across various studies have been conflicting, highlighting the need for more consistent data to understand how THC-containing cannabis affects IBD patients.
The Role of the Endocannabinoid System
Our bodies have a built-in endocannabinoid system (ECS) that helps regulate various functions, including immune responses in the gut. However, this system can sometimes become dysregulated.
Gut Bacteria and Receptor Activity
Research shared via bioRxiv examined how cannabinoid receptor 1 activity might influence the environment of the colon. The study observed that activity in this system may stimulate the expansion of certain bacteria (Enterobacteriaceae) in an oxygen-dependent manner. The researchers suggested that this activity could promote metabolic dysfunction in the colonic mucosa and that an increase in gut endocannabinoids is associated with microbial dysbiosis in those with Crohn's disease.
Systemic Impact on Muscle Health
The influence of the ECS extends beyond the digestive tract. A narrative review in Experimental Gerontology discussed how the ECS acts as a regulator for skeletal muscle plasticity. The authors suggested that there is a complex interplay between the ECS and non-communicable diseases that may contribute to muscle degeneration, suggesting a need for further research into this triad of factors.
Other Areas of Study
While not focused exclusively on cannabis, other recent research explores different pathways for managing inflammation and its secondary effects:
- Low-Dose CBD: A review in the British Journal of Clinical Pharmacology examined the safety and pharmacokinetics of low-dose cannabidiol (CBD), specifically doses of 175 mg/day or less, to better understand how the body processes these smaller amounts.
- Inflammation and Mood: A study in Neuroscience Bulletin used murine models to examine how a compound called muscone might address depression triggered by peripheral inflammation, such as that caused by colitis.
- Immune Response: Research in Molecular Therapy identified a molecule called neuritin (NRN) that may help restrain certain T cell responses in autoimmune and inflammatory diseases.
Consult Your Healthcare Provider
The relationship between cannabis, the gut microbiome, and inflammatory diseases is complex. Some studies suggest potential benefits for symptom management, while others highlight how the endocannabinoid system may interact with gut bacteria in ways that require careful monitoring.
Because every patient's chemistry is different, please talk to your physician to determine if medical cannabis is an appropriate addition to your specific care plan.
Sources & references
These peer-reviewed studies are indexed on PubMed (U.S. National Library of Medicine); each links to its PubMed listing. Findings belong to the cited authors and journals.
- Muscone Exerts Rapid Antidepressant Effects Through Modulating Glutamatergic Neural Transmission in the Anterior Cingulate Cortex Against Peripheral Inflammation-induced Depression. — Neuroscience bulletin · PubMed
- Evaluating the pharmacokinetics, efficacy and safety of low-dose cannabidiol. — British journal of clinical pharmacology · PubMed
- Effectiveness of THC-containing cannabis for inflammatory bowel disease: a systematic review. — Journal of cannabis research · PubMed
- Endocannabinoid system dysregulation in non-communicable diseases: implications for skeletal muscle health. — Experimental gerontology · PubMed
- Administration of neuritin as a novel therapeutic strategy for autoimmune and inflammatory diseases. — Molecular therapy : the journal of the American Society of Gene Therapy · PubMed
- Cannabinoid receptor 1 activity promotes microbial dysbiosis by stimulating the oxygen-dependent expansion of Enterobacteriaceae. — bioRxiv : the preprint server for biology · PubMed
Ready to get your Florida medical marijuana card?
Disabled veteran-owned · on-site physician · no hidden fees.